Share-based Payment Arrangement, Expense of Bioventus Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bioventus Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Bioventus Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $3,242,000, a 48% increase year-over-year.
  • Bioventus Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $12,193,000, a 5% decline year-over-year.
  • Bioventus Inc. annual Share-based Payment Arrangement, Expense for 2025 was $12,193,000, a 5% decline from 2024.
  • Bioventus Inc. annual Share-based Payment Arrangement, Expense for 2024 was $12,829,000, a 441% increase from 2023.
  • Bioventus Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2,370,000, a 86% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bioventus Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $12,193,000 $3,242,000 +$1,057,000 +48% 28 Sep 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 $11,136,000 $3,176,000 +$685,000 +27% 29 Jun 2025 27 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $10,451,000 $3,361,000 -$2,201,000 -40% 30 Mar 2025 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $12,652,000 $2,414,000 -$177,000 -6.8% 01 Jan 2025 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $12,829,000 $2,185,000 29 Sep 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 $2,491,000 30 Jun 2024 28 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $5,562,000 31 Mar 2024 29 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $2,591,000 01 Jan 2024 30 Mar 2024 10-Q 07 May 2024 2024 Q1

Bioventus Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,193,000 -$636,000 -5% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $12,829,000 +$10,459,000 +441% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $2,370,000 -$14,744,000 -86% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2026 2025 FY
2022 $17,114,000 -$2,390,000 -12% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 $19,504,000 01 Jan 2021 31 Dec 2021 10-K 12 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.